Since the creation of Abiogen Pharma, the strategic choice has been to enhance and develop the know how gained through years of manufacturing and the skills acquired in pharmaceutical development.
The Abiogen Manufacturing aim is to manage both the manufacturing and development of the projects and products of Abiogen Pharma, and the development of manufacturing for external clients.
Compliance to the GCP for clinical studies and the GMP for production, is constantly monitored by periodic internal inspections to the studies and the production processes. Maintenance, upgrading and continuous growth of know how is made possible by regular customer audits, representing a rare opportunity for analysis and comparison with the greatest representatives of the quality and manufacturing sector. The results of these audits through the respective services of Quality Assurance are further evidence that Abiogen Pharma’s Pharmaceutical Factory offers an adequate and consistent sphere of quality assurance.
The knowledge and expertise acquired over many years of activity supporting research in the development of products from Abiogen’s product list, makes Pharmaceutical Development one of the strengths of the Business Manufacturing area.
The department consists of an area equipped for production and a quality control unit for Investigation Medicinal Products (IMPs) which operate according to the EU-GMP Good Manufacturing Practices Annex 13.
The production unit has an area for the production of IMPs for clinical phases III-IV (pilot scale).
Analytical laboratories, well equipped with the latest state-of-art machinery, assure the timely release of IMPs. The areas have been GMP accredited for Good Manufacturing Practices EU-GMP annex 13 since 2005.
The activities developed and the successes obtained in the last decade confirm the vision of Abiogen Pharma towards a range of services aimed at creating a real value to the projects undertaken and building a synergistic partnership with its customers.
The offer is developed through the provision of high-quality standards, significant and certified technical-scientific competence and the technological capacity available in the various strategic areas of Manufacturing, Pharmaceutical Development, Purchasing, Quality Unit, Legal Affairs, Logistic and Customer Care and a network of suppliers specialized in quality.
The projects are evaluated in their complexity and carefully analyzed according to the state of the art regulatory requirements and the value is sought for each project phase by ensuring competitive prices aligned to the European market.
Contract Manufacturing, Pharmaceutical Development services and Clinical Supply are the sectors of excellence of Abiogen Pharma’s service contracts.
The site located on the outskirts of Pisa in Ospedaletto is spread along an area of 120.000 m2 and a covered area of 26.000 m2.
The premises were designed to align Abiogen Pharma Manufacturing to the state of the art in European pharmaceutical production and pharmaceutical development.
The flows of materials and personnel meet the strict requirements of the G.M.P (Good Manufacturing Practices) in Europe.
The layout of the site is considered to be at today’s cutting edge of new pharmaceutical plant construction. It was designed according to the concept of dedicated units per single formulation, each equipped with one or more independent HVAC systems and dedicated entrances for the personnel and materials, respecting the most stringent requirements set by the European GMP (Good Manufacturing Practice).
Particular attention was paid to the environmental impact of an industrial plant of such dimensions, equipped with its own electrical generator powered by methane, which through the co-generation plant, permits the simultaneous and constant production of hot and cold water, saving both energy and reducing toxic emissions.
Two artificial lakes, built to avoid the use of tap water, secure the cooling of the industrial plants and irrigation of the green areas. Extreme attention was paid to structure rationalization with particular care of the production flows.
The entire production activity is continuously monitored through an Emerson computerized system that can detect, and, if necessary, restore in real-time all key parameters of the production equipment through digital sensors and optic transmissions.
Total plant surface | 120.000 mq. |
Roofed surface | 26.000 mq. |
Raw materials warehouse | 3.400 mq. |
Finished product warehouse | 3.000 mq. |
Pharmaceutical manufacturing | 10.000 mq. |
Pharmaceutical development | 1.080 mq. |
Quality control laboratories | 1.080 mq. |
Services and Utilities | 2.000 mq. |
Offices | 5.400 mq. |
This production area covers a surface of about 1.800 mq.
Production capacities:
350/400 tons/ year.
Orals solids process:
Manufacturing equipment:
Packaging equipment oral solid
Production capacities:
30 million/year pieces
Type of products:
Packaging equipment:
type of blisters:
This production area covers a surface of about 1105 mq.
Production capacities:
Equipment:
Packaging:
Type of packaging:
This production area covers a surface of about 200 mq.
Production capacities:
Equipment:
Packaging:
This production area covers a surface of about 800 mq.
Production capacities:
45 million/year oral liquid forms: syrups, drops, lotions
Equipment:
Type of containers:
This production area covers a surface of about 800 mq.
Production capacities:
Equipment:
Production capacities:
800.000/year pieces
Equipment:
Equipment
Twin-Pack Blistering machine O.M.A.R.
Technology
PVC/ALU – PVC-PVDC/ALU
Capability / Typical range
7 cycles/minute
Equipment
aminar Air Flow (dedicated for API of clinical phase III-IV)
Technology
Sampling and Dispensing
Equipment
Multi Processor MP1 (laboratory fluid bed dryer) GEA Niro Pharma System
Technology
Mixing, Drying, agglomeration, top spray coating
Capability / Typical range
6 Kg – 8 Kg (16 litres capacity)
Equipment
PharmaConnect® (Through-the-Wall) GEA Niro Pharma System
Equipment
Lab Mini Blender Module
Technology
Mixing
Capability / Typical range
Bin 3 litres 450 g -1,2 Kg – Bin 5 litres 750 g -2,0 Kg – Bin 15 litres 2,25 Kg -6 Kg
Equipment
High Shear Mixer
Technology
Granulation
Capability / Typical range
Develop. scale (3 litres Bowl size) 720 g -1.35 Kg – Pilot scale (30 litres Bowl size) 7.2 Kg – 13.5 Kg
Equipment
Thermotron T 7510 (Static Essiccator)
Technology
Drying
Equipment
IMILL-F 5’’ Calibrating mill IMA
Technology
Calibration of wet or dry products
Capability / Typical range
Square holes (6-8-10 mm) Mainly used for wet granulation Round holes (0.35-6 mm) Mainly used for dry granulation
Equipment
Ronchi EA8 (High-speed rotary tablet presses)
Technology
Tabletting
Capability / Typical range
4,800-24,000 tablets/hour
Equipment
Kramer E80 (De-duster)
Equipment
GS HTM/25 Tablet-coating equipment
Technology
Tablet coating
Capability / Typical range
25 litres
Equipment
Peristaltic pump Watson&Marlow, mod. 520Di
Technology
Liquid and Semi-solid (creams, gels, lotions and ointments)
Equipment
Sotax automatic tester AT 7 smart
Technology
Dissolution
Capability
2 systems